SXTP (STOCKS)
60 Degrees Pharmaceuticals, Inc. Common Stock
$1.899900
+0.139900 (+7.95%)
Prev close: $1.760000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Geoffrey S. Dow
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $5.19M
- Employees
- 3
- P/E (TTM)
- -0.12
- P/B (TTM)
- -0.34
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $1.01M |
| Benefits Costs and Expenses | $8.37M |
| Cost Of Revenue | $781.70K |
| Costs And Expenses | $8.37M |
| Gross Profit | $223.78K |
| Nonoperating Income/Loss | $390.25K |
| Operating Expenses | $8.39M |
| Research and Development | $2.11M |
| Other Operating Expenses | $6.28M |
| Operating Income/Loss | -$7.76M |
| Income/Loss From Continuing Operations After Tax | -$7.37M |
| Income/Loss From Continuing Operations Before Tax | -$7.37M |
| Income Tax Expense/Benefit | $0.00 |
| Income Tax Expense/Benefit, Current | $0.00 |
| Income Tax Expense/Benefit, Deferred | $0.00 |
| Net Income/Loss | -$7.37M |
| Net Income/Loss Attributable To Noncontrolling Interest | -$3.17K |
| Net Income/Loss Attributable To Parent | -$7.37M |
| Net Income/Loss Available To Common Stockholders, Basic | -$7.86M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $501.06K |
| Preferred Stock Dividends And Other Adjustments | $501.06K |
| Basic Earnings Per Share | -$11.73 |
| Diluted Earnings Per Share | -$11.73 |
| Basic Average Shares | 670,211 |
| Diluted Average Shares | 670,211 |
| Assets | $5.37M |
| Current Assets | $4.90M |
| Cash | $2.75M |
| Inventory | $656.92K |
| Other Current Assets | $1.49M |
| Noncurrent Assets | $470.73K |
| Fixed Assets | $246.37K |
| Intangible Assets | $224.36K |
| Non-current Prepaid Expenses | $0.00 |
| Liabilities | $1.99M |
| Current Liabilities | $1.84M |
| Noncurrent Liabilities | $144.00K |
| Long-term Debt | $150.00K |
| Equity | $3.38M |
| Equity Attributable To Noncontrolling Interest | -$83.76K |
| Equity Attributable To Parent | $3.46M |
| Liabilities And Equity | $5.37M |
| Net Cash Flow From Operating Activities | -$6.85M |
| Net Cash Flow From Operating Activities, Continuing | -$6.85M |
| Net Cash Flow From Investing Activities | $254.92K |
| Net Cash Flow From Investing Activities, Continuing | $254.92K |
| Net Cash Flow From Financing Activities | $6.44M |
| Net Cash Flow From Financing Activities, Continuing | $6.44M |
| Exchange Gains/Losses | $7.13K |
| Net Cash Flow | -$149.29K |
| Net Cash Flow, Continuing | -$156.42K |
| Comprehensive Income/Loss | -$7.36M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | -$3.17K |
| Comprehensive Income/Loss Attributable To Parent | -$7.36M |
| Other Comprehensive Income/Loss | $7.13K |